Fontolizumab

Fontolizumab

Monoclonal antibody
Type	Whole antibody
Source	Humanized (from mouse)
Target	interferon gamma
Clinical data
ATC code	none
Identifiers
CAS Number	326859-36-3 N
ChemSpider	none
UNII	6J92H2439Z
KEGG	D04242 Y
Chemical and physical data
Molar mass	ca. 150 kg/mol
NY (what is this?)  (verify)

Fontolizumab (planned trade name HuZAF) is a humanized monoclonal antibody and an immunosuppressive drug for the treatment of auto-immune diseases like Crohn's disease. A phase II clinical trial investigating the use for rheumatoid arthritis was terminated because the first phase did not meet the endpoint.